Diversified Trust Co Acquires Shares of 1,047 CME Group Inc. (NASDAQ:CME)

Diversified Trust Co acquired a new stake in CME Group Inc. (NASDAQ:CME - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 1,047 shares of the financial services provider's stock, valued at approximately $278,000.

Several other hedge funds also recently modified their holdings of CME. New Age Alpha Advisors LLC raised its position in CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after acquiring an additional 43 shares in the last quarter. Alpine Bank Wealth Management acquired a new position in shares of CME Group during the 1st quarter worth about $32,000. Knuff & Co LLC acquired a new position in shares of CME Group during the 4th quarter worth about $33,000. Banque Transatlantique SA bought a new stake in shares of CME Group in the 4th quarter valued at about $35,000. Finally, United Community Bank bought a new stake in shares of CME Group in the 4th quarter valued at about $37,000. Institutional investors own 87.75% of the company's stock.

CME Group Stock Performance

Shares of CME traded down $1.00 during midday trading on Thursday, reaching $274.83. 1,234,017 shares of the stock were exchanged, compared to its average volume of 2,194,406. The stock's 50 day simple moving average is $276.00 and its 200 day simple moving average is $257.35. The company has a market cap of $99.04 billion, a P/E ratio of 27.65, a PEG ratio of 3.75 and a beta of 0.44. CME Group Inc. has a twelve month low of $193.17 and a twelve month high of $290.79. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, topping analysts' consensus estimates of $2.61 by $0.19. The business had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 57.71% and a return on equity of 14.03%. CME Group's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period last year, the firm earned $2.50 earnings per share. On average, sell-side analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th were issued a dividend of $1.25 per share. The ex-dividend date of this dividend was Monday, June 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.82%. CME Group's dividend payout ratio is presently 50.30%.

Insider Buying and Selling

In related news, Director Charles P. Carey sold 500 shares of the business's stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total value of $132,675.00. Following the completion of the transaction, the director owned 4,900 shares of the company's stock, valued at $1,300,215. The trade was a 9.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Phyllis M. Lockett sold 1,060 shares of the company's stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $277.88, for a total transaction of $294,552.80. Following the sale, the director directly owned 3,108 shares of the company's stock, valued at $863,651.04. This represents a 25.43% decrease in their position. The disclosure for this sale can be found here. Insiders sold 13,400 shares of company stock valued at $3,680,610 in the last quarter. Corporate insiders own 0.30% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Erste Group Bank cut CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Barclays lifted their target price on CME Group from $279.00 to $283.00 and gave the stock an "equal weight" rating in a research note on Wednesday, April 23rd. Royal Bank Of Canada reissued a "sector perform" rating and set a $269.00 target price on shares of CME Group in a report on Thursday, April 3rd. Morgan Stanley raised their price target on CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a report on Thursday, April 24th. Finally, Keefe, Bruyette & Woods lifted their price objective on shares of CME Group from $265.00 to $273.00 and gave the stock a "market perform" rating in a research report on Thursday, April 24th. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $259.87.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.